102 related articles for article (PubMed ID: 15824741)
1. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors.
Chen LL; Sabripour M; Wu EF; Prieto VG; Fuller GN; Frazier ML
Oncogene; 2005 Jun; 24(26):4271-80. PubMed ID: 15824741
[TBL] [Abstract][Full Text] [Related]
2. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
3. A recurrent duodenal gastrointestinal stromal tumor with a frameshift mutation resulting in a stop codon in KIT exon 13.
Vu HA; Xinh PT; Kikushima M; Zhu Y; Tokuhara M; Tani M; Shimizu T; Saito K; Tokunaga K; Sato Y
Genes Chromosomes Cancer; 2005 Feb; 42(2):179-83. PubMed ID: 15543597
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
[TBL] [Abstract][Full Text] [Related]
5. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors.
Lasota J; Miettinen M
Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562
[TBL] [Abstract][Full Text] [Related]
6. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
7. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.
Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK
Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563
[TBL] [Abstract][Full Text] [Related]
8. Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript.
Lasota J; Kopczynski J; Majidi M; Miettinen M; Sarlomo-Rikala M
Am J Pathol; 2002 Aug; 161(2):739-41. PubMed ID: 12163399
[No Abstract] [Full Text] [Related]
9. The emergence of alternative 3' and 5' splice site exons from constitutive exons.
Koren E; Lev-Maor G; Ast G
PLoS Comput Biol; 2007 May; 3(5):e95. PubMed ID: 17530917
[TBL] [Abstract][Full Text] [Related]
10. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
Ma DL; Liu XH; Bai CG; Xie Q; Feng F
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
[TBL] [Abstract][Full Text] [Related]
11. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E
Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
14. Mutation of acceptor splice site of the SEDL gene in X-linked spondyloepiphyseal dysplasia tarda causes the activation of cryptic splice site.
Ma HW; Jiang J; Lu JF; Guo R; Niu GH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):251-3. PubMed ID: 15952107
[TBL] [Abstract][Full Text] [Related]
15. Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors.
Agaram NP; Besmer P; Wong GC; Guo T; Socci ND; Maki RG; DeSantis D; Brennan MF; Singer S; DeMatteo RP; Antonescu CR
Clin Cancer Res; 2007 Jan; 13(1):170-81. PubMed ID: 17200352
[TBL] [Abstract][Full Text] [Related]
16. SNPSplicer: systematic analysis of SNP-dependent splicing in genotyped cDNAs.
ElSharawy A; Manaster C; Teuber M; Rosenstiel P; Kwiatkowski R; Huse K; Platzer M; Becker A; Nürnberg P; Schreiber S; Hampe J
Hum Mutat; 2006 Nov; 27(11):1129-34. PubMed ID: 16937379
[TBL] [Abstract][Full Text] [Related]
17. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.
Wardelmann E; Merkelbach-Bruse S; Pauls K; Thomas N; Schildhaus HU; Heinicke T; Speidel N; Pietsch T; Buettner R; Pink D; Reichardt P; Hohenberger P
Clin Cancer Res; 2006 Mar; 12(6):1743-9. PubMed ID: 16551858
[TBL] [Abstract][Full Text] [Related]
19. Exon inclusion is dependent on predictable exonic splicing enhancers.
Zhang XH; Kangsamaksin T; Chao MS; Banerjee JK; Chasin LA
Mol Cell Biol; 2005 Aug; 25(16):7323-32. PubMed ID: 16055740
[TBL] [Abstract][Full Text] [Related]
20. Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells.
Sambol EB; Ambrosini G; Geha RC; Kennealey PT; Decarolis P; O'connor R; Wu YV; Motwani M; Chen JH; Schwartz GK; Singer S
Cancer Res; 2006 Jun; 66(11):5858-66. PubMed ID: 16740725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]